ANGLE PLC
A liquid biopsy company with a system to capture circulating tumor cells from blood.
AGL | IL
Overview
Corporate Details
- ISIN(s):
- GB0034330679 (+3 more)
- LEI:
- 213800BY11K6W3NMS374
- Country:
- United Kingdom
- Address:
- GROUND FLOOR, 10 NUGENT ROAD, GU2 7AF GUILDFORD
- Website:
- https://angleplc.com/
- Industry:
- Other human health activities
Description
ANGLE PLC is a liquid biopsy company that has developed the proprietary Parsortix® system for cancer diagnostics and research. The system uses a patented, size-based microfluidic technology to capture and harvest intact, live circulating tumor cells (CTCs) and CTC clusters from patient blood for downstream analysis. The company's commercial offerings are focused on two main areas: diagnostic products and clinical services. Products include the FDA-cleared, automated Parsortix PC1 instrument and its associated single-use cassettes for use in clinical laboratories. The company also provides global laboratory services from its GCP-compliant facilities, supporting biopharmaceutical companies and translational research projects with complete CTC harvesting and analysis solutions. These applications aid in drug development, patient monitoring, and the advancement of personalized medicine in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-09 17:36 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2022-03-02 19:29 |
Holding(s) in Company
|
English | 19.7 KB | ||
| 2022-02-18 18:13 |
Issue of Equity
|
English | 17.5 KB | ||
| 2022-01-21 08:00 |
Potential in immunotherapy treatment selection
|
English | 19.8 KB | ||
| 2022-01-17 08:00 |
Concordance of Parsortix with tissue biopsy
|
English | 22.1 KB | ||
| 2022-01-13 08:00 |
Update on lab accreditation and ovarian study
|
English | 17.1 KB | ||
| 2022-01-10 08:00 |
Insight into drug resistance in NSCLC
|
English | 23.4 KB | ||
| 2021-12-22 19:29 |
Issue of Equity
|
English | 17.7 KB | ||
| 2021-12-01 19:11 |
Issue of Equity
|
English | 18.3 KB | ||
| 2021-12-01 08:00 |
Parsortix in RNA analysis of CTCs as tool in NSCLC
|
English | 21.4 KB | ||
| 2021-11-26 18:33 |
Issue of Equity
|
English | 17.7 KB | ||
| 2021-11-17 11:32 |
Issue of Equity
|
English | 17.6 KB | ||
| 2021-11-15 08:00 |
Issue of LTIP Options and Share Options
|
English | 44.6 KB | ||
| 2021-11-15 08:00 |
Appointment of Chief Medical Officer
|
English | 18.0 KB | ||
| 2021-11-12 18:51 |
Issue of Equity
|
English | 17.6 KB |
Automate Your Workflow. Get a real-time feed of all ANGLE PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANGLE PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANGLE PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
